{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:19:39Z","timestamp":1789172379574,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA172855"],"award-info":[{"award-number":["R01CA172855"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019708","name":"UroGen Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.urology.2022.12.009","type":"journal-article","created":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T21:40:41Z","timestamp":1671918041000},"page":"134-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Natural History of Multiple Recurrences in Intermediate-Risk Non-Muscle Invasive Bladder Cancer: Lessons From a Prospective Cohort"],"prefix":"10.1016","volume":"173","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4715-5451","authenticated-orcid":false,"given":"Vidit","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Chamie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Schoenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Fero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Lec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie R.","family":"Munneke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Aaronson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence H.","family":"Kushi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles P.","family":"Quesenberry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn L.","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2022.12.009_bib0001","unstructured":"SEER STATS. Available at: https:\/\/seer.cancer.gov\/statfacts\/html\/urinb.html. Accessed December 1, 2021."},{"key":"10.1016\/j.urology.2022.12.009_bib0002","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.juro.2016.06.049","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline","volume":"196","author":"Chang","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2022.12.009_bib0003","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2022.12.009_bib0004","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/j.juro.2009.07.016","article-title":"Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model","volume":"182","author":"Fernandez-Gomez","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2022.12.009_bib0005","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.juro.2014.02.2573","article-title":"Defining and treating the spectrum of intermediate risk nonmuscle invasive bladder cancer","volume":"192","author":"Kamat","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2022.12.009_bib0006","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven eortc trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2022.12.009_bib0007","first-page":"187","article-title":"The Be-Well Study: a prospective cohort study of lifestyle and genetic factors to reduce the risk of recurrence and progression of non-muscle-invasive bladder cancer","volume":"30","author":"Kwan","year":"2019","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.urology.2022.12.009_bib0008","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1093\/aje\/kwx133","article-title":"Prediction of multiple recurrent events: a comparison of extended cox models in bladder cancer","volume":"186","author":"Smedinga","year":"2017","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.urology.2022.12.009_bib0009","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1308\/003588410X12664192076935","article-title":"Mechanisms of recurrence of Ta\/T1 bladder cancer","volume":"92","author":"Bryan","year":"2010","journal-title":"Ann R Coll Surg Engl"},{"key":"10.1016\/j.urology.2022.12.009_bib0010","first-page":"3681","article-title":"Shorter recurrence-free survival time, higher risk of multiple recurrences: a retrospective study of non-muscle invasive bladder cancer after transurethral resection","volume":"125","author":"Deng","year":"2012","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.urology.2022.12.009_bib0011","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0090-4295(01)01435-2","article-title":"Risk factors for multiple intravesical recurrences of superficial bladder cancer","volume":"58","author":"Hisataki","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.urology.2022.12.009_bib0012","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.urolonc.2016.05.028","article-title":"Follow-up in non-muscle-invasive bladder cancer-international bladder cancer network recommendations","volume":"34","author":"Kassouf","year":"2016","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urology.2022.12.009_bib0013","article-title":"Biomarkers and intermediate-high risk non-muscle invasive bladder cancer: a multivariate analysis of three different cellular pathways with pronostic implications","author":"Garde-Garc\u00eda","year":"2020","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.urology.2022.12.009_bib0014","doi-asserted-by":"crossref","first-page":"e16426","DOI":"10.1097\/MD.0000000000016426","article-title":"Predicting recurrence of nonmuscle-invasive bladder cancer (Ta-T1): A study based on 477 patients","volume":"98","author":"Lu","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.urology.2022.12.009_bib0015","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.acuro.2014.04.007","article-title":"Risk estimation of multiple recurrence and progression of non muscle invasive bladder carcinoma using new mathematical models","volume":"38","author":"Luj\u00e1n","year":"2014","journal-title":"Actas Urol Esp"},{"key":"10.1016\/j.urology.2022.12.009_bib0016","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2298\/VSP131030072M","article-title":"Difference in recurrence frequencies of non-muscle-invasive-bladder tumors depending on optimal usage of intravesical immunotherapy of bacillus Calmette-Gu\u00e9rin","volume":"72","author":"Milo\u0161evi\u0107","year":"2015","journal-title":"Vojnosanit Pregl"},{"key":"10.1016\/j.urology.2022.12.009_bib0017","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.euo.2022.05.005","article-title":"Intermediate-risk non-muscle-invasive bladder cancer: updated consensus definition and management recommendations from the international bladder cancer group","volume":"5","author":"Tan","year":"2022","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.urology.2022.12.009_bib0018","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1158\/1078-0432.CCR-17-2719","article-title":"Molecular markers increase precision of the european association of urology non-muscle-invasive bladder cancer progression risk groups","volume":"24","author":"van Kessel","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urology.2022.12.009_bib0019","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/path.2507","article-title":"The development of multiple bladder tumour recurrences in relation to the FGFR3 mutation status of the primary tumour","volume":"218","author":"Kompier","year":"2009","journal-title":"J Pathol"},{"key":"10.1016\/j.urology.2022.12.009_bib0020","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s12253-018-0431-7","article-title":"Androgen receptor predicts first and multiple recurrences in non-muscle invasive urothelial carcinoma of the bladder","volume":"25","author":"Yonekura","year":"2019","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.urology.2022.12.009_bib0021","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.euf.2019.04.021","article-title":"Androgen Suppression Therapy Is Associated with Lower Recurrence of Non-muscle-invasive Bladder Cancer","volume":"7","author":"Wu","year":"2021","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.urology.2022.12.009_bib0022","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.eururo.2018.02.014","article-title":"Repeat Transurethral Resection in Non-muscle-invasive Bladder Cancer: A Systematic Review","volume":"73","author":"Cumberbatch","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2022.12.009_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/S0302-2838(21)01140-4","article-title":"Implications of guideline-based, risk-stratified restaging transurethral resection of high-grade Ta urothelial carcinoma on bacillus calmette-gu\u00e9rin therapy outcomes","author":"Hensley","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.urology.2022.12.009_bib0024","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1001\/jama.2018.4657","article-title":"Effect of intravesical instillation of gemcitabine vs saline immediately following resection of suspected low-grade non-muscle-invasive bladder cancer on tumor recurrence: SWOG S0337 randomized clinical trial","volume":"319","author":"Messing","year":"2018","journal-title":"JAMA"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429522010718?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429522010718?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:04:18Z","timestamp":1758769458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429522010718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":24,"alternative-id":["S0090429522010718"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2022.12.009","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural History of Multiple Recurrences in Intermediate-Risk Non-Muscle Invasive Bladder Cancer: Lessons From a Prospective Cohort","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2022.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}